This association also occurred for BC patients who had decreased plasma CEA (ng/mL) levels, increased insulin (μIU/mL) levels, IR, or increased plasma leptin (ng/mL) levels (Table 5). The gene discussed is CEACAM5; the disease is breast cancer.